Both HIF3A and CITED4 were hypermethylated and downregulated in the HLRCC tumors consistent with enhancing the HIF1α-driven activation of the HIF pathway. This evidence concerns the gene CITED4 and hereditary leiomyomatosis and renal cell cancer.